Efficacy and Safety of Immunosuppressive Therapy for PBC–AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study
Aim. To explore the efficacy and safety of immunosuppressive therapy for the treatment of primary biliary cirrhosis-autoimmune hepatitis (PBC-AIH) overlap syndrome accompanied by decompensated cirrhosis. Methods. A cohort study was performed to evaluate the usefulness of immunosuppressive therapy in...
Saved in:
Main Authors: | Xiaoli Fan, Yongjun Zhu, Ruoting Men, Maoyao Wen, Yi Shen, Changli Lu, Li Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/1965492 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving Survival in Decompensated Cirrhosis
by: Amar Nath Mukerji, et al.
Published: (2012-01-01) -
Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
by: Pooja D. Amarapurkar, et al.
Published: (2011-01-01) -
Progressive systemic inflammation precedes decompensation in compensated cirrhosis
by: Rubén Sánchez-Aldehuelo, et al.
Published: (2025-02-01) -
Cytokines in Liver Cirrhosis (Their Importance in Assessing Activity and Decompensation)
by: G. K. Mirodzhov, et al.
Published: (2023-11-01) -
Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis
by: K. S. Zemlyanukhina, et al.
Published: (2024-10-01)